1-170539515-G-T
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_152281.3(GORAB):c.367G>T(p.Glu123*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,613,924 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_152281.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- geroderma osteodysplasticaInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet, Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_152281.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GORAB | NM_152281.3 | MANE Select | c.367G>T | p.Glu123* | stop_gained | Exon 2 of 5 | NP_689494.3 | ||
| GORAB | NM_001410894.1 | c.316G>T | p.Glu106* | stop_gained | Exon 2 of 5 | NP_001397823.1 | |||
| GORAB | NM_001146039.2 | c.367G>T | p.Glu123* | stop_gained | Exon 2 of 4 | NP_001139511.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GORAB | ENST00000367763.8 | TSL:2 MANE Select | c.367G>T | p.Glu123* | stop_gained | Exon 2 of 5 | ENSP00000356737.4 | ||
| GORAB | ENST00000367762.2 | TSL:1 | c.367G>T | p.Glu123* | stop_gained | Exon 2 of 4 | ENSP00000356736.2 | ||
| GORAB | ENST00000498166.6 | TSL:1 | n.*361G>T | non_coding_transcript_exon | Exon 4 of 7 | ENSP00000473336.2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152188Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000121 AC: 3AN: 248940 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461736Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727174 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74336 show subpopulations
ClinVar
Submissions by phenotype
Geroderma osteodysplastica Pathogenic:1
not provided Pathogenic:1
This sequence change creates a premature translational stop signal (p.Glu148*) in the GORAB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GORAB are known to be pathogenic (PMID: 18997784, 19681135). This variant is present in population databases (rs119455951, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with gerodermia osteodysplastica (PMID: 18997784). It has also been observed to segregate with disease in related individuals. This variant is also known as Glu123X. ClinVar contains an entry for this variant (Variation ID: 2650). For these reasons, this variant has been classified as Pathogenic.
GORAB-related disorder Pathogenic:1
The GORAB c.442G>T variant is predicted to result in premature protein termination (p.Glu148*). In this literature, this variant is also referred to as p.Glu123X. This variant has been reported in the homozygous state in several individuals with gerodermia osteodysplasticum (Hennies et al. 2008. PubMed ID: 18997784). This variant is reported in 0.0027% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Nonsense variants in GORAB are expected to be pathogenic. This variant is interpreted as pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at